Cargando…

A clinical evaluation of Kanchanara Guggulu and Bala Taila Matra Basti in the management of Mutraghata with special reference to benign prostatic hyperplasia

BACKGROUND: Mutraghata a disease of Mutravaha Srotasa (urinary system) described in Ayurveda, closely resembles with benign prostatic hyperplasia (BPH) of the modern medicine. It affects man above the age of 40 years. Conservative management with hormonal therapy, open prostatectomy and TURP are the...

Descripción completa

Detalles Bibliográficos
Autores principales: Banothe, Gajiram Dharamdas, Mahanta, Vyasdeva, Gupta, Sanjay Kumar, Dudhamal, Tukaram S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369605/
https://www.ncbi.nlm.nih.gov/pubmed/30783359
http://dx.doi.org/10.4103/ayu.AYU_117_15
_version_ 1783394222304395264
author Banothe, Gajiram Dharamdas
Mahanta, Vyasdeva
Gupta, Sanjay Kumar
Dudhamal, Tukaram S.
author_facet Banothe, Gajiram Dharamdas
Mahanta, Vyasdeva
Gupta, Sanjay Kumar
Dudhamal, Tukaram S.
author_sort Banothe, Gajiram Dharamdas
collection PubMed
description BACKGROUND: Mutraghata a disease of Mutravaha Srotasa (urinary system) described in Ayurveda, closely resembles with benign prostatic hyperplasia (BPH) of the modern medicine. It affects man above the age of 40 years. Conservative management with hormonal therapy, open prostatectomy and TURP are the options available in modern medicine. In Ayurveda, the drugs having Vata Kapha pacifying action, Shothahara (anti-inflammatory) and Mutrala (diuretic) are recommended for its management. AIM: The aim of this study was to evaluate the clinical efficacy of Kanchanara Guggulu orally and Bala Taila Matra Basti in the management of Mutraghata (BPH). MATERIALS AND METHODS: A total of 32 selected patients were divided into two groups. In group A, Bala Taila 60 ml, Matra Basti, once a day, was administered just before breakfast for 21 days. In group B, Bala Taila (60 ml), Matra Basti, once a day, was administered just before breakfast for 21 days and Kanchanara Guggulu Vati 1g (2 tab, 500mg each) three times a day, orally with lukewarm water was administered for 21 days. Findings were recorded in research proforma at weekly interval and patients were followed up till 1 month. RESULTS: In group A, the maximum improvement was seen in 3 patients (25.00%), moderate improvement was seen in 8 patients (66.67%) and mild improvement was observed in 1 patient (8.34%). Similarly, in group B, the maximum improvement was found in 10 patients (55.56%), moderate improvement in 7 patients (38.89%) and mild improvement in 1 patient (5.56%) only. None of the patients got complete remission or remained unchanged in either of the groups. Significant reduction was observed in postvoidal residual urine volume and the size of the prostate in both the groups. CONCLUSION: It was concluded that Matra Basti along with Kanchanara Guggulu orally showed Mutraghata comparatively better symptomatic relief as compared to Matra Basti alone in cases of Mutraghata (BPH).
format Online
Article
Text
id pubmed-6369605
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-63696052019-02-19 A clinical evaluation of Kanchanara Guggulu and Bala Taila Matra Basti in the management of Mutraghata with special reference to benign prostatic hyperplasia Banothe, Gajiram Dharamdas Mahanta, Vyasdeva Gupta, Sanjay Kumar Dudhamal, Tukaram S. Ayu Original Article BACKGROUND: Mutraghata a disease of Mutravaha Srotasa (urinary system) described in Ayurveda, closely resembles with benign prostatic hyperplasia (BPH) of the modern medicine. It affects man above the age of 40 years. Conservative management with hormonal therapy, open prostatectomy and TURP are the options available in modern medicine. In Ayurveda, the drugs having Vata Kapha pacifying action, Shothahara (anti-inflammatory) and Mutrala (diuretic) are recommended for its management. AIM: The aim of this study was to evaluate the clinical efficacy of Kanchanara Guggulu orally and Bala Taila Matra Basti in the management of Mutraghata (BPH). MATERIALS AND METHODS: A total of 32 selected patients were divided into two groups. In group A, Bala Taila 60 ml, Matra Basti, once a day, was administered just before breakfast for 21 days. In group B, Bala Taila (60 ml), Matra Basti, once a day, was administered just before breakfast for 21 days and Kanchanara Guggulu Vati 1g (2 tab, 500mg each) three times a day, orally with lukewarm water was administered for 21 days. Findings were recorded in research proforma at weekly interval and patients were followed up till 1 month. RESULTS: In group A, the maximum improvement was seen in 3 patients (25.00%), moderate improvement was seen in 8 patients (66.67%) and mild improvement was observed in 1 patient (8.34%). Similarly, in group B, the maximum improvement was found in 10 patients (55.56%), moderate improvement in 7 patients (38.89%) and mild improvement in 1 patient (5.56%) only. None of the patients got complete remission or remained unchanged in either of the groups. Significant reduction was observed in postvoidal residual urine volume and the size of the prostate in both the groups. CONCLUSION: It was concluded that Matra Basti along with Kanchanara Guggulu orally showed Mutraghata comparatively better symptomatic relief as compared to Matra Basti alone in cases of Mutraghata (BPH). Medknow Publications & Media Pvt Ltd 2018 /pmc/articles/PMC6369605/ /pubmed/30783359 http://dx.doi.org/10.4103/ayu.AYU_117_15 Text en Copyright: © 2019 AYU (An International Quarterly Journal of Research in Ayurveda) http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Banothe, Gajiram Dharamdas
Mahanta, Vyasdeva
Gupta, Sanjay Kumar
Dudhamal, Tukaram S.
A clinical evaluation of Kanchanara Guggulu and Bala Taila Matra Basti in the management of Mutraghata with special reference to benign prostatic hyperplasia
title A clinical evaluation of Kanchanara Guggulu and Bala Taila Matra Basti in the management of Mutraghata with special reference to benign prostatic hyperplasia
title_full A clinical evaluation of Kanchanara Guggulu and Bala Taila Matra Basti in the management of Mutraghata with special reference to benign prostatic hyperplasia
title_fullStr A clinical evaluation of Kanchanara Guggulu and Bala Taila Matra Basti in the management of Mutraghata with special reference to benign prostatic hyperplasia
title_full_unstemmed A clinical evaluation of Kanchanara Guggulu and Bala Taila Matra Basti in the management of Mutraghata with special reference to benign prostatic hyperplasia
title_short A clinical evaluation of Kanchanara Guggulu and Bala Taila Matra Basti in the management of Mutraghata with special reference to benign prostatic hyperplasia
title_sort clinical evaluation of kanchanara guggulu and bala taila matra basti in the management of mutraghata with special reference to benign prostatic hyperplasia
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369605/
https://www.ncbi.nlm.nih.gov/pubmed/30783359
http://dx.doi.org/10.4103/ayu.AYU_117_15
work_keys_str_mv AT banothegajiramdharamdas aclinicalevaluationofkanchanaragugguluandbalatailamatrabastiinthemanagementofmutraghatawithspecialreferencetobenignprostatichyperplasia
AT mahantavyasdeva aclinicalevaluationofkanchanaragugguluandbalatailamatrabastiinthemanagementofmutraghatawithspecialreferencetobenignprostatichyperplasia
AT guptasanjaykumar aclinicalevaluationofkanchanaragugguluandbalatailamatrabastiinthemanagementofmutraghatawithspecialreferencetobenignprostatichyperplasia
AT dudhamaltukarams aclinicalevaluationofkanchanaragugguluandbalatailamatrabastiinthemanagementofmutraghatawithspecialreferencetobenignprostatichyperplasia
AT banothegajiramdharamdas clinicalevaluationofkanchanaragugguluandbalatailamatrabastiinthemanagementofmutraghatawithspecialreferencetobenignprostatichyperplasia
AT mahantavyasdeva clinicalevaluationofkanchanaragugguluandbalatailamatrabastiinthemanagementofmutraghatawithspecialreferencetobenignprostatichyperplasia
AT guptasanjaykumar clinicalevaluationofkanchanaragugguluandbalatailamatrabastiinthemanagementofmutraghatawithspecialreferencetobenignprostatichyperplasia
AT dudhamaltukarams clinicalevaluationofkanchanaragugguluandbalatailamatrabastiinthemanagementofmutraghatawithspecialreferencetobenignprostatichyperplasia